1. Home
  2. VKTX vs CATY Comparison

VKTX vs CATY Comparison

Compare VKTX & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • CATY
  • Stock Information
  • Founded
  • VKTX 2012
  • CATY 1962
  • Country
  • VKTX United States
  • CATY United States
  • Employees
  • VKTX N/A
  • CATY N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • CATY Major Banks
  • Sector
  • VKTX Health Care
  • CATY Finance
  • Exchange
  • VKTX Nasdaq
  • CATY Nasdaq
  • Market Cap
  • VKTX 3.8B
  • CATY 3.2B
  • IPO Year
  • VKTX 2015
  • CATY N/A
  • Fundamental
  • Price
  • VKTX $35.22
  • CATY $45.80
  • Analyst Decision
  • VKTX Strong Buy
  • CATY Hold
  • Analyst Count
  • VKTX 14
  • CATY 5
  • Target Price
  • VKTX $87.00
  • CATY $50.80
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • CATY 336.5K
  • Earning Date
  • VKTX 10-22-2025
  • CATY 10-21-2025
  • Dividend Yield
  • VKTX N/A
  • CATY 2.97%
  • EPS Growth
  • VKTX N/A
  • CATY 9.40
  • EPS
  • VKTX N/A
  • CATY 4.33
  • Revenue
  • VKTX N/A
  • CATY $711,617,000.00
  • Revenue This Year
  • VKTX N/A
  • CATY $17.40
  • Revenue Next Year
  • VKTX N/A
  • CATY $6.77
  • P/E Ratio
  • VKTX N/A
  • CATY $10.57
  • Revenue Growth
  • VKTX N/A
  • CATY N/A
  • 52 Week Low
  • VKTX $18.92
  • CATY $36.06
  • 52 Week High
  • VKTX $79.10
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 60.22
  • CATY 41.26
  • Support Level
  • VKTX $33.00
  • CATY $45.89
  • Resistance Level
  • VKTX $36.11
  • CATY $47.63
  • Average True Range (ATR)
  • VKTX 2.02
  • CATY 1.56
  • MACD
  • VKTX 0.09
  • CATY -0.11
  • Stochastic Oscillator
  • VKTX 73.40
  • CATY 14.19

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: